Indication: Sickle Cell Disease (SCD)

A Non-Myeloablative Conditioning and Transplantation of Partially HLA-Mismatched and HLA-Matched Bone Marrow for Patients with Sickle Cell Disease and Other Hemoglobinopathies

Sub-indication: Sickle Cell Disease (SCD)

Study Type: Specimen Study

Principal Investigator: William Tse, M.D.
Norton Children's Cancer Institute, affiliated with the UofL School of Medicine

Sponsor: Sponsor: Vanderbilt-Ingram Cancer Center

Search our entire site.